2025 |
KalVista Pharmaceuticals Inc
|
Chairman of the Board |
- |
- |
2024 |
ProKidney Corp - Ordinary Shares - Class A
|
Independent Director |
252.9 K |
-39.9 % |
2024 |
KalVista Pharmaceuticals Inc
|
Chairman of the Board |
161.6 K |
49.8 % |
2023 |
ProKidney Corp - Ordinary Shares - Class A
|
Independent Director |
421.1 K |
-95.7 % |
2023 |
KalVista Pharmaceuticals Inc
|
Chairman of the Board |
107.9 K |
-46.1 % |
2022 |
ProKidney Corp - Ordinary Shares - Class A
|
Independent Director |
9.7 M |
- |
2022 |
KalVista Pharmaceuticals Inc
|
Independent Director |
200.3 K |
77.1 % |
2021 |
KalVista Pharmaceuticals Inc
|
Independent Director |
113.1 K |
138.0 % |
2021 |
ProKidney Corp - Ordinary Shares - Class A
|
Director |
- |
- |
2020 |
KalVista Pharmaceuticals Inc
|
Independent Director |
47.5 K |
-75.2 % |
2020 |
Abeona Therapeutics Inc
|
Executive Chairman of the Board |
- |
- |
2019 |
KalVista Pharmaceuticals Inc
|
Independent Director |
191.5 K |
- |